Sue Yom, MD, PhD
Dr. Sue S. Yom, MD, PhD, MAS, FASTRO, FAAWR, FACR is the Vice Chair of Strategic Advisory and the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in the Departments of Radiation Oncology and Otolaryngology Head and Neck Surgery at the University of California San Francisco. She is the Editor-in-Chief of the International Journal of Radiation Oncology Biology Physics, Chair of the NRG Oncology Head and Neck Cancer Committee, and the Guidelines and Protocols Committee Co-Chair and Board Member for the Head and Neck Cancer International Group. She is also a Board Member of the RTOG Foundation and the patient advocacy organization Head and Neck Cancer Alliance. She is a Past President of the American Radium Society and was the founding Chair of the ARS Appropriate Use Criteria Committees. She is a member of the NCCN Head and Neck Cancers guidelines committee and AJCC HPV+ Oropharynx Cancer Expert Panel and is a member of the Head and Neck Cancer Resource Panel, Science Education Program Development, and Health Equity Diversity Inclusion Education Committees of the American Society of Radiation Oncology. At UCSF, she serves as Co-Chair of the Oral Head and Neck Site Committee, Contact PI for NRG Oncology, and Full Member in Molecular Oncology for the Helen Diller Family Comprehensive Cancer Center. She holds research grants from NIH, industry, and foundations and has been author or co-author on over 250 publications in the medical literature. She has served on expert panels and scientific organizing committees for numerous professional societies.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Bristol Myers SquibbTopic:nasopharynx cancerDate added:03/29/2024Date updated:03/29/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:EMD SeronoTopic:head and neck cancerDate added:03/29/2024Date updated:03/29/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:NanobiostixTopic:head and neck cancerDate added:03/29/2024Date updated:03/29/2024